Cart
sales@molnova.com
RBN013209
CAS No. 2597933-17-8
RBN013209( —— )
Catalog No. M28545 CAS No. 2597933-17-8
RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 141 | In Stock |
|
| 5MG | 128 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRBN013209
-
NoteResearch use only, not for human use.
-
Brief DescriptionRBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
-
DescriptionRBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorcPLA2α|Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2597933-17-8
-
Formula Weight384.43
-
Molecular FormulaC19H24N6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (260.13 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakamura H, et al. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004 Jan 19;484(1):9-17.
molnova catalog
related products
-
ID-8
ID-8, a DYRK inhibitor, sustains embryonic stem cell self-renewal in long-term culture.
-
Lauryl maltose neope...
Lauryl maltose neopentyl glycol (LMNG) is a detergent that solubilizes and stabilizes membrane proteins by extracting intact proteins from membranes, thereby enhancing the stability of entities such as G protein-coupled receptors and respiratory system complexes.
-
1-Methylnicotinamide...
Niacin metabolite excreted via the urinary system.
